AMPEL BioSolutions

Jul 15, 2024

Lupus Treatment with Omega3-Rich Krill Oil Improves Disease Activity

Apr 23, 2024

AMPEL BioSolutions Selected as Member of ARPA-H Customer Experience Hub Spoke Network

Jun 09, 2020

Virginia Based AMPEL BioSolutions' Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments

Jan 17, 2020

AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco

Jul 09, 2019

Virginia Based AMPEL BioSolutions' Machine Learning Breakthrough Predicts Chronic Disease Flares From A Blood Sample

May 16, 2019

Data Analysis Published in Hypertension Shows Responders to Pegloticase Treatment Had Significant Decreases in Blood Pressure

Apr 23, 2019

AMPEL BioSolutions and MedNet Solutions Partner to Host Virginia Biotechnology Association Networking and Educational Event

Mar 21, 2019

New Insights on an Ancient Disease and Evidence of Effective Therapy

Jan 02, 2019

AMPEL BioSolutions Announces Proof That A Novel Treatment Rapidly Eliminates Uric Acid Build Up in Gout Patients

Oct 25, 2018

AMPEL's System For Drug Repositioning Confirmed By Success Of Phase 2 Trial Of Stelara In Lupus

Dec 05, 2017

AMPEL BioSolutions, Horizon Pharma plc, and Lupus Research Alliance Partner on Unique Clinical Trial for Patients with Lupus

Nov 07, 2017

Growing Biomedical Research Organization AMPEL BioSolutions Selects Montrium as eTMF Partner